Sea Buckthorn.

Sea buckthorn oil carries palmitoleic, oleic and linoleic acids plus carotenoids, all of which degrade through radical chain oxidation. Tocopherol is lipid soluble and terminates that chain inside the oil droplet, preserving both the fatty acids and the carotenoid colour.

Carotenoids are hydrophobic and need dietary fat to form the mixed micelles that deliver them to the intestinal cell. Sea buckthorn is an oil-bearing fruit, so its own fat phase carries co-dosed beta carotene into that micelle rather than leaving it undissolved.

Sea buckthorn berries are themselves an unusually dense ascorbate source, and ascorbate regenerates the tocopherol radical back to active vitamin E in the same oil fraction. The two nutrients work as a redox pair inside the berry and in the formula.

The omega-7 palmitoleic acid in sea buckthorn feeds the lipid side of skin and mucosal barriers, while hyaluronic acid holds water in the same tissue. One supplies the lipid, the other the water phase.

Collagen peptides supply the glycine and proline building blocks of the dermal matrix, and sea buckthorn contributes the fatty acid and carotenoid side of skin structure. Skin formulas pair the protein and lipid contributions.

Evening primrose oil supplies gamma-linolenic acid, an omega-6 that sits downstream of the desaturase step, while sea buckthorn supplies omega-7 and omega-3 from the seed and pulp. The formula therefore covers more than one fatty acid class.

Both carry oxygenated and hydrocarbon carotenoids that partition into cell membranes and quench singlet oxygen. Combined they extend coverage across the lipid phase, though they also share micellar uptake.

Carotenoids are absorbed through the same mixed micelles and the same intestinal transporters, so the carotenes in sea buckthorn and xanthophylls such as lutein compete when given in one dose. High amounts of one lower the plasma response to the other.

Carotenoids and tocopherols need dietary fat to form the micelles that carry them across the intestinal wall. A lipid carrier in the same dose raises the fraction absorbed.

Ceramides are the structural lipids of the outer skin layer and sea buckthorn omega-7 supports the sebaceous and mucosal lipid film above them. The two act on adjacent layers of the same barrier.

Zinc is required by the metalloenzymes that drive keratinocyte division and matrix remodelling. It supplies the enzymatic side of skin renewal that the fatty acids and carotenoids of sea buckthorn feed structurally.

Sea buckthorn seed oil supplies linoleic and alpha-linolenic acids in roughly balanced proportion, while marine oil supplies the long-chain EPA and DHA that alpha-linolenic acid converts to only inefficiently in humans. Pairing them covers both the parent and the elongated forms. The oils are compositionally complementary, which is a formulation fact rather than a combined effect claim.

Sea buckthorn appears among the herbs reviewed for platelet aggregation inhibiting activity, and marine oils have their own well-documented effect on platelet function. Stacking two agents that act on the same process is worth flagging for anyone already on antiplatelet or anticoagulant medication. This is an interaction to disclose, not a benefit to promote.

Nattokinase has fibrinolytic activity and sea buckthorn is named in a systematic review of herbs with platelet aggregation inhibiting evidence. Two agents acting on different points of the same cascade compound the effect. Flagged so a formula does not stack them silently.

Ginkgo terpene lactones are long associated with platelet aggregation inhibition, and sea buckthorn is listed among herbs with evidence in the same review. Combining them raises the additive concern rather than the additive benefit. Anyone on blood-thinning medication should have this on the label.

Allium sulfur compounds inhibit platelet aggregation through thromboxane-related routes, and sea buckthorn appears in the same body of herbal platelet literature. The two together act on one process from two directions. Named as a caution.

Gingerols have reported antiplatelet activity in laboratory and small human work, and sea buckthorn is named among reviewed herbs with the same class of activity. The combination is additive on the same endpoint. Early confidence, disclosed rather than promoted.

Salicylates from willow bark act on cyclooxygenase-dependent platelet activation. Placed alongside a botanical that appears in the platelet aggregation inhibition literature, the effects add. This pairing is a flag, not a formulation recommendation.

Gamma-linolenic acid sits one desaturation step downstream of linoleic acid, which sea buckthorn seed oil supplies. Delivering both the parent and the desaturated form bypasses the delta-6 desaturase step that limits conversion in some people. A pathway relationship, not a measured outcome.

Both oils supply alpha-linolenic acid, so pairing them raises total intake of the same fatty acid rather than adding a new one. Sea buckthorn seed oil differs in also carrying carotenoids, tocopherols and a near-equal linoleic share. Understand this as overlap, which may be the intent or may be redundancy depending on the formula.

Linoleic acid is one of the two dominant fatty acids in sea buckthorn seed oil, so adding it separately increases the same input. Linoleic and alpha-linolenic acids compete for the same desaturase enzymes, which is why their ratio matters more than either amount alone. Established lipid biochemistry.

Sea buckthorn pulp oil is unusually carotenoid dense and provides the lipid vehicle that xanthophyll absorption requires, since carotenoids must be incorporated into mixed micelles to be taken up. Zeaxanthin delivered in the same oil phase benefits from that vehicle. The vehicle relationship is established; how much more is absorbed depends on the formulation.

Carotenoids compete with one another for space in mixed micelles and for the same intestinal transporters, so a large dose of one can reduce the uptake of another taken at the same time. Sea buckthorn already delivers a substantial carotenoid load. Spacing high-dose single carotenoids apart from a carotenoid-rich oil is the usual handling.

Adequate preformed retinol downregulates the intestinal cleavage of beta-carotene to retinal, a feedback mechanism that limits how much of a provitamin A carotenoid is converted. Sea buckthorn supplies provitamin A carotenoids rather than retinol. Naming this keeps the two from being counted as the same input.

Sea buckthorn berries carry flavonol glycosides including isorhamnetin, a methylated quercetin derivative, along with quercetin and kaempferol conjugates. Adding quercetin therefore reinforces a class the berry already supplies and draws on the same conjugation and efflux pathways. Overlap, which can mean reinforcement or redundancy depending on the amounts.

Piperine slows UDP-glucuronosyltransferase conjugation and P-glycoprotein efflux, which is the documented basis for its use with flavonoids and polyphenols. Sea buckthorn flavonols are extensively conjugated after absorption, so the mechanism applies in principle. It has not been measured for this berry specifically.

Phospholipid emulsifiers help disperse a carotenoid-rich oil into fine droplets, which increases the surface area available for lipase and for micellar incorporation. That is the standard basis for lecithin in oil-based formulations. It changes delivery, not the constituent profile.

Phosphatidylcholine is the principal emulsifying phospholipid in bile and in formulated lipid vehicles, and carotenoid and tocopherol uptake depends on micelle formation. Co-formulating it with a fruit or seed oil is a delivery decision. Established formulation chemistry.

Sea buckthorn berries are notably high in ascorbic acid, and ascorbate reduces ferric to ferrous iron and keeps it soluble at duodenal pH, which is a well-established enhancer of non-haem iron uptake. How much a given berry preparation contributes depends on its actual vitamin C content, which is lost to heat and oxygen during processing. The mechanism is established; the berry's contribution is preparation-dependent.

Enzyme-assisted extraction combined with lactic acid bacteria fermentation increased measured bioactivity of sea buckthorn juice in laboratory testing, largely by releasing bound phenolics from their glycosides. That is a processing effect measured in vitro rather than a co-ingestion effect in people. It is why fermented sea buckthorn preparations exist as a distinct category.

Plantarum strains carry glycosidase activity that hydrolyses flavonol glycosides to their aglycones during fermentation. Fermented sea buckthorn juice showed enhanced bioactivity in laboratory measurement. The result is an in vitro compositional change, not a demonstrated human outcome.

Sea buckthorn berries reduced markers of liver injury in chickens fed a hepatotoxin, and silymarin has its own long liver-marker literature. Both are placed in liver-support formulas on that basis. The sea buckthorn side of this is an animal study measuring markers, so the pairing sits at Early and should not be presented as a human effect.

Squalane is a stable saturated emollient, while sea buckthorn pulp oil carries palmitoleic acid and a heavy carotenoid load that stains and oxidises. Blending the two moderates colour and improves oxidative stability of the finished oil phase. This is formulation practice rather than a biological interaction.